Clinical Trial Update: Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status [NA]

View source ↗

Summary

This clinical trial on lymphedema prophylaxis for high-risk breast cancer survivors has completed and posted its results in March 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lymphedema

Snippet

Sponsor: Stanford University | Conditions: Lymphedema, Breast Cancer | NA | Status: COMPLETED | Results posted: 2017-03-30